Biomedicine and Pharmacotherapy
Q1 Journal
Open Access
Journal
Country
France
Western Europe
Subject Area and Category
Medicine
└
Medicine (miscellaneous)
Q1
└
Pharmacology
Q1
Publisher
SJR 2025
2.074
Q1
SJR Score
H-Index
196
Citations / Doc (2yr)
9.84
Total Docs. (latest)
1,039
Total Citations (3yr)
49,563
Publication type
Journals
ISSN
07533322, 19506007
Coverage
1982-2026
Journal Rank
#1,337
Subject Categories
Medicine (miscellaneous)
Q1
Pharmacology
Q1
Subject Areas
Aims & Scope
Biomedicine & Pharmacotherapy is a multidisciplinary journal which publishes full-length, original research reports, reviews, and preliminary communications or letters to the editor which fall within the general scope of clinical and basic medicine and pharmacology.
The general fields of interest will include Cancer, Nutriceutics, Neurodegenerative, Cardiac and Infectious Diseases.
Special emphasis will be placed on studies of specific topics such as molecular mechanisms, gene regulation in normal and pathologic cells as well as susceptibility in response to oncogenic agents.
Effects of drugs on preclinical and clinical pharmacology and the role of bacteria, viruses and parasites in animals and humans.
Brief reports of meetings, symposia and conferences will also be considered for publication as well as brief listings of scientific meetings or academic courses of interest to the readers
Abstracting & Indexing
Scopus
Google Scholar
Web of Science
Medline
Embase
Detailed Metrics
| Total Docs. (latest) | 1,039 |
| Total Docs. (3 years) | 5,006 |
| Total Refs. | 85,929 |
| Total Citations (3 years) | 49,563 |
| Citable Docs. (3 years) | 4,986 |
| Citations / Doc. (2 years) | 9.84 |
| Ref. / Doc. | 82.70 |
| % Female | 48.4% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.